rs1800600

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_003975.4(SH2D2A):​c.123+19C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.68 in 1,609,636 control chromosomes in the GnomAD database, including 373,314 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.65 ( 32702 hom., cov: 31)
Exomes 𝑓: 0.68 ( 340612 hom. )

Consequence

SH2D2A
NM_003975.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.797

Publications

12 publications found
Variant links:
Genes affected
SH2D2A (HGNC:10821): (SH2 domain containing 2A) This gene encodes an adaptor protein thought to function in T-cell signal transduction. A related protein in mouse is responsible for the activation of lymphocyte-specific protein-tyrosine kinase and functions in downstream signaling. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2010]
NTRK1 (HGNC:8031): (neurotrophic receptor tyrosine kinase 1) This gene encodes a member of the neurotrophic tyrosine kinase receptor (NTKR) family. This kinase is a membrane-bound receptor that, upon neurotrophin binding, phosphorylates itself and members of the MAPK pathway. The presence of this kinase leads to cell differentiation and may play a role in specifying sensory neuron subtypes. Mutations in this gene have been associated with congenital insensitivity to pain, anhidrosis, self-mutilating behavior, cognitive disability and cancer. Alternate transcriptional splice variants of this gene have been found, but only three have been characterized to date. [provided by RefSeq, Jul 2008]
NTRK1 Gene-Disease associations (from GenCC):
  • hereditary sensory and autonomic neuropathy type 4
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, ClinGen, Labcorp Genetics (formerly Invitae)
  • familial medullary thyroid carcinoma
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 1-156815987-G-A is Benign according to our data. Variant chr1-156815987-G-A is described in ClinVar as [Benign]. Clinvar id is 667768.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.797 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SH2D2ANM_003975.4 linkc.123+19C>T intron_variant Intron 2 of 8 ENST00000368199.8 NP_003966.2 Q9NP31-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SH2D2AENST00000368199.8 linkc.123+19C>T intron_variant Intron 2 of 8 1 NM_003975.4 ENSP00000357182.3 Q9NP31-1

Frequencies

GnomAD3 genomes
AF:
0.655
AC:
99054
AN:
151310
Hom.:
32670
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.575
Gnomad AMI
AF:
0.793
Gnomad AMR
AF:
0.700
Gnomad ASJ
AF:
0.681
Gnomad EAS
AF:
0.818
Gnomad SAS
AF:
0.653
Gnomad FIN
AF:
0.660
Gnomad MID
AF:
0.705
Gnomad NFE
AF:
0.677
Gnomad OTH
AF:
0.659
GnomAD2 exomes
AF:
0.676
AC:
167391
AN:
247594
AF XY:
0.676
show subpopulations
Gnomad AFR exome
AF:
0.565
Gnomad AMR exome
AF:
0.693
Gnomad ASJ exome
AF:
0.697
Gnomad EAS exome
AF:
0.813
Gnomad FIN exome
AF:
0.647
Gnomad NFE exome
AF:
0.673
Gnomad OTH exome
AF:
0.670
GnomAD4 exome
AF:
0.682
AC:
994688
AN:
1458206
Hom.:
340612
Cov.:
42
AF XY:
0.682
AC XY:
494642
AN XY:
725294
show subpopulations
African (AFR)
AF:
0.565
AC:
18895
AN:
33426
American (AMR)
AF:
0.696
AC:
30914
AN:
44396
Ashkenazi Jewish (ASJ)
AF:
0.689
AC:
17965
AN:
26062
East Asian (EAS)
AF:
0.817
AC:
32389
AN:
39642
South Asian (SAS)
AF:
0.662
AC:
56899
AN:
85986
European-Finnish (FIN)
AF:
0.651
AC:
34696
AN:
53298
Middle Eastern (MID)
AF:
0.723
AC:
4168
AN:
5764
European-Non Finnish (NFE)
AF:
0.683
AC:
757301
AN:
1109348
Other (OTH)
AF:
0.688
AC:
41461
AN:
60284
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.451
Heterozygous variant carriers
0
15876
31751
47627
63502
79378
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19474
38948
58422
77896
97370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.655
AC:
99137
AN:
151430
Hom.:
32702
Cov.:
31
AF XY:
0.658
AC XY:
48687
AN XY:
73954
show subpopulations
African (AFR)
AF:
0.575
AC:
23750
AN:
41308
American (AMR)
AF:
0.700
AC:
10666
AN:
15234
Ashkenazi Jewish (ASJ)
AF:
0.681
AC:
2352
AN:
3452
East Asian (EAS)
AF:
0.817
AC:
4167
AN:
5098
South Asian (SAS)
AF:
0.654
AC:
3153
AN:
4820
European-Finnish (FIN)
AF:
0.660
AC:
6957
AN:
10536
Middle Eastern (MID)
AF:
0.716
AC:
209
AN:
292
European-Non Finnish (NFE)
AF:
0.676
AC:
45787
AN:
67684
Other (OTH)
AF:
0.657
AC:
1387
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1763
3526
5290
7053
8816
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
802
1604
2406
3208
4010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.642
Hom.:
13681
Bravo
AF:
0.658
Asia WGS
AF:
0.708
AC:
2462
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Hereditary insensitivity to pain with anhidrosis Benign:1
Jul 08, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.45
DANN
Benign
0.65
PhyloP100
-0.80
PromoterAI
-0.0048
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1800600; hg19: chr1-156785779; API